Cargando…

Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement

Various meningococcal conjugate vaccines exist against serogroups A, C, W and Y. A new protein-based vaccine targeting serogroup B (MenB) is also now available. The potential of such vaccines to drive serogroup replacement is considered a possible public health concern when implementing nationwide r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hogea, Cosmina, Van Effelterre, Thierry, Vyse, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049729/ https://www.ncbi.nlm.nih.gov/pubmed/26308796 http://dx.doi.org/10.1080/21645515.2015.1080400

Ejemplares similares

A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures?
por: Hogea, Cosmina, et al.
Publicado: (2014)

Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada
por: Breton, Marie-Claude, et al.
Publicado: (2020)

Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
por: Patton, Monica E., et al.
Publicado: (2017)

A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection
por: Hogea, Cosmina, et al.
Publicado: (2015)

Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom
por: Van Effelterre, Thierry P, et al.
Publicado: (2015)

Routine vaccination against MenB: Considerations for implementation
por: Kaaijk, Patricia, et al.
Publicado: (2014)

Multi‐component meningococcal serogroup B (MenB)‐4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency
por: van den Broek, B., et al.
Publicado: (2019)

Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine
por: Green, Luke R., et al.
Publicado: (2018)

01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Young Adults
por: Coyne-Beasley, Tamera, et al.
Publicado: (2021)

Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States
por: Rajam, Gowrisankar, et al.
Publicado: (2017)

The Long Road to an Effective Vaccine for Meningococcus Group B (MenB)
por: Shea, Michael W.
Publicado: (2013)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

Modelling the cost-effectiveness of catch-up ‘MenB’ (Bexsero) vaccination in England
por: Christensen, Hannah, et al.
Publicado: (2017)

A physician’s guide to the 2-dose schedule of MenB-FHbp vaccine
por: McDaniel, Angee, et al.
Publicado: (2019)

Perceptions and Knowledge About the MenB Vaccine Among Parents of High School Students
por: Richardson, Eric, et al.
Publicado: (2021)

Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage
por: Sereikaitė, Emilija, et al.
Publicado: (2023)

Erratum for Rajam et al., “Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States”
por: Rajam, Gowrisankar, et al.
Publicado: (2019)

UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis
por: Jackson, Cath, et al.
Publicado: (2017)

Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme
por: Tirani, Marcello, et al.
Publicado: (2015)

Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015)
por: Tryfinopoulou, Kyriaki, et al.
Publicado: (2016)

A basic dynamic transmission model of Staphylococcus aureus in the US population
por: HOGEA, C., et al.
Publicado: (2014)

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data
por: Beeslaar, Johannes, et al.
Publicado: (2020)

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies
por: Beeslaar, Johannes, et al.
Publicado: (2020)

Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018–2020
por: Stefanizzi, Pasquale, et al.
Publicado: (2022)

State-Level Variations and Factors Associated with Adult Vaccination Coverage: A Multilevel Modeling Approach
por: Garbinsky, Diana, et al.
Publicado: (2021)

2722. Effects of Sex, Age, and Race on Immunogenicity of MenB-FHbp, a Bivalent Meningococcal B Vaccine: A Pooled Evaluation of Clinical Trial Data
por: Beeslaar, Johannes, et al.
Publicado: (2019)

2459. Meningococcal ACWY (MenACWY) Vaccination of Adolescents in the United States: How Compliant Are We With the Advisory Committee on Immunization Practices (ACIP) Recommendations?
por: Cheng, Wendy, et al.
Publicado: (2018)

6. Pentavalent Meningococcal (MenABCWY) Vaccine is Safe and Well Tolerated With Immunogenicity Noninferior to Coadministered MenB-FHbp and MenACWY-CRM in a Phase 2 Study of Healthy Adolescents and Young Adults
por: Peterson, James, et al.
Publicado: (2020)

Serogroup C meningococci in Italy in the era of conjugate menC vaccination
por: Stefanelli, Paola, et al.
Publicado: (2009)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
por: Serra, Lidia, et al.
Publicado: (2021)

An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability
por: La, Elizabeth M., et al.
Publicado: (2017)

‘Be on the TEAM’ Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents
por: Carr, Jeremy, et al.
Publicado: (2020)

87. Impact of State of Residence on Adult Vaccination Uptake: A Multilevel Modeling Approach
por: Hunter, Shannon, et al.
Publicado: (2020)

Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States
por: Talbird, Sandra E, et al.
Publicado: (2020)

1414. #Vaccine Twitter Influencers: is it Just About Reach and Followers?
por: Poirrier, Jean-Etienne, et al.
Publicado: (2020)

Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction
por: Martinelli, Domenico, et al.
Publicado: (2015)

The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?
por: Curran, Desmond, et al.
Publicado: (2016)

2726. Meningococcal Vaccination Among Patients Newly Diagnosed at High-Risk for Meningococcal Disease in the United States
por: Bengtson, Lindsay, et al.
Publicado: (2019)

Determinants of Meningococcal ACWY vaccination in adolescents in the US: completion and compliance with the CDC recommendations
por: Cheng, Wendy Y., et al.
Publicado: (2019)

Isolation and characterization of mutants corresponding to the MENA, MENB, MENC and MENE enzymatic steps of 5′‐monohydroxyphylloquinone biosynthesis in Chlamydomonas reinhardtii
por: Emonds‐Alt, Barbara, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0j1o9fj7ikb0ac96kdo79ad1f0